Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2
- PMID: 20454865
- DOI: 10.1007/s10969-010-9091-x
Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2
Abstract
The nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) fusion oncoprotein, formed by the t(2;5) chromosomal translocation in anaplastic large-cell lymphomas, has constitutive tyrosine kinase activity and interacts with a number of signaling molecules. One of the interacting partners of NPM-ALK is the adaptor protein, Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target (SNT), and mutations that deprive NPM-ALK of all three of the SNT-binding sites significantly reduced the transforming activity. In this study, the interactions of the three binding sites in NPM-ALK with the phosphotyrosine binding (PTB) domain of SNT-2 were analyzed. First, by isothermal titration calorimetry, we found that the phosphorylation-independent binding site in NPM-ALK interacts with the SNT-2 PTB domain more tightly than the phosphorylation-dependent binding sites. Second, the solution structure of the SNT-2 PTB domain in complex with the nonphosphorylated NPM-ALK peptide was determined by nuclear magnetic resonance spectroscopy. The NPM-ALK peptide interacts with the hydrophobic surface of the PTB domain and intermolecularly extends the PTB beta-sheet. This interaction mode is much broader and more extensive than those of the phosphorylation-dependent binding sites. Our results indicate that the higher binding activity of the phosphorylation-independent binding site is caused by additional hydrophobic interactions.
Similar articles
-
Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.Oncogene. 2007 May 3;26(20):2950-4. doi: 10.1038/sj.onc.1210095. Epub 2006 Nov 6. Oncogene. 2007. PMID: 17086210
-
Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).J Biol Chem. 2003 Aug 8;278(32):30028-36. doi: 10.1074/jbc.M300883200. Epub 2003 May 14. J Biol Chem. 2003. PMID: 12748172
-
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.Blood. 2007 Oct 1;110(7):2600-9. doi: 10.1182/blood-2006-01-028647. Epub 2007 May 30. Blood. 2007. PMID: 17537995 Free PMC article.
-
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22. Blood. 2017. PMID: 27879258 Review.
-
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.Leukemia. 2000 Sep;14(9):1533-59. doi: 10.1038/sj.leu.2401878. Leukemia. 2000. PMID: 10994999 Review.
Cited by
-
Impact of the Protein Data Bank on antineoplastic approvals.Drug Discov Today. 2020 May;25(5):837-850. doi: 10.1016/j.drudis.2020.02.002. Epub 2020 Feb 14. Drug Discov Today. 2020. PMID: 32068073 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases